Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ATAI
Stock Latest News
Ratings
AtaiBeckley: Strong Buy Rating Backed by Promising Clinical Data and Robust Financial Position
23h ago
ATAI
Premium
The Fly
Psychedelic: Atai Beckley, Cybin report quarterly earnings
7d ago
PBM
ABBV
Premium
Ratings
ATAI Life Sciences’ BPL-003 Gains Momentum with Breakthrough Therapy Designation and Strategic Merger, Reinforcing Buy Rating
7d ago
ATAI
Premium
Ratings
ATAI Life Sciences: Promising Clinical Developments and Strong Financial Position Drive Buy Rating
7d ago
ATAI
Premium
Company Announcements
AtaiBeckley Advances Mental Health Therapies with FDA Milestone
8d ago
ATAI
Premium
The Fly
Atai Beckley reports Q3 EPS (28c), consensus (12c)
8d ago
ATAI
Premium
The Fly
Atai Beckley sees cash runway into 2029
8d ago
ATAI
Premium
Ratings
ATAI Life Sciences’ BPL-003 Shows Promising Phase 2b Results, Earning Buy Rating
10d ago
ATAI
Premium
The Fly
GH Research price target lowered to $35 from $40 at H.C. Wainwright
10d ago
ABBV
ATAI
Premium
Ratings
Buy Rating Affirmed on Promising Clinical Data and Strategic Developments for AtaiBeckley
10d ago
ATAI
Premium
The Fly
Atai Beckley announces data from Phase 2b OLE study of BPL-003
10d ago
ATAI
Premium
The Fly
Psychedelic: Compass Pathways, GH Research report Q3 earnings
14d ago
PBM
ATAI
Premium
Company Announcements
ATAI Life Sciences Files Prospectus for Share Resale
15d ago
8K
ATAI
Premium
Company Announcements
ATAI Life Sciences Completes Acquisition of Beckley Psytech
15d ago
8K
ATAI
Premium
The Fly
Atai Life Sciences completes combination between atai Life, Beckley Psytech
15d ago
ATAI
Premium
Company Announcements
ATAI Life Sciences Approves Beckley Psytech Acquisition
16d ago
8K
ATAI
Premium
The Fly
Psychedelic: Compass Pathways, NeuroKaire enter R&D collaboration
21d ago
ATAI
CMND
Premium
Ratings
ATAI Life Sciences: Promising Growth in Psychedelics Market with Strong Pipeline and Strategic Positioning
27d ago
ATAI
Premium
The Fly
Atai Life Sciences moved to Buy rating at Berenberg
27d ago
ATAI
Premium
The Fly
Psychedelic: Clearmind enrolls last patient in first cohort of CMND-100 trial
28d ago
ATAI
CMND
Premium
The Fly
Atai Life Sciences price target raised to $14 from $11 at Canaccord
29d ago
ATAI
Premium
Company Announcements
ATAI Life Sciences Closes $149.5 Million Public Offering
1M ago
8K
ATAI
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
